PrecisCa
PrecisCa supports patients, their caregivers, and health care providers at every step of their cancer journeys from diagnosis to remission, with up-to-date education on the latest advancements in cancer care and access to leading specialists to analyze patient scenarios
Heme Tumor Board: 78 y/o Male Presents for a Second Opinion for Newly Diagnosed Monoclonal Gammopathy for Renal Significance With Kappa Light Chain Restriction
Comments 0
Login to view comments.
Click here to Login
